Skip to content

Wave Life Sciences, Inc.

WVE· NasdaqCore metricsCIK 1631574

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -7.61%
Market cap
$622.26M
197.23M shares
Filings
744
$13.16M
Q3 2026−60.5% FY25 yoy
-$61.91M
Q3 2026N/M FY25 yoy
-$66.05M
Q3 2026N/M FY25 yoy
-$174.61M
Q3 2026derivedN/M FY25 yoy
-$0.30
Q3 2026N/M FY25 yoy
$197.32M
Q3 2026+99.3% FY25 yoy
$622.26M
—
8.8×
1.5×
-33.49%
—

Twelve months to Sep 30, 2026 · derived

Price

$3.1656.54%$4.11past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$42.73MFY 2025
$113.31M0FY 2015FY 2020FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$42,727,000reported
FY 20242024-12-31$108,302,000reported
FY 20232023-12-31$113,305,000reported
FY 20222022-12-31$3,649,000reported
FY 20212021-12-31$40,964,000reported
FY 20202020-12-31$20,077,000reported
FY 20192019-12-31$15,983,000reported
FY 20182018-12-31$14,414,000reported
FY 20172017-12-31$3,893,000 revisedreported
FY 20162016-12-31$1,092,000 revisedreported
FY 20152015-12-31$152,000reported

Pharmaceutical preparations

Wave Life Sciences, Inc. is the 136th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Wave Life Sciences, Inc. · CIK 1631574 · Engraved from SEC EDGAR